The present invention relates to a synergistic formulation comprising the essential oils of plants from western Himalayas, which have versatile medicinal properties. The present invention also relates to a process for development of synergistic value added anti-acnes products using the essential oils from these plants of western Himalayas. The developed synergistic formulation is useful in inhibiting different P. acnes strains thereby exhibiting antibacterial activity.

The present invention relates to a synergistic formulation comprising the essential oils of plants from western Himalayas, which have versatile medicinal properties. The present invention also relates to a process for development of synergistic value added anti-acnes products using the essential oils from these plants of western Himalayas. The developed synergistic formulation is useful in inhibiting different P. acnes strains thereby exhibiting antibacterial activity.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix B shows significant effect on increased insulin secretion and glucose uptake by cells.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix B shows significant effect on increased insulin secretion and glucose uptake by cells.

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix B shows significant effect on increased insulin secretion and glucose uptake by cells.

Veterinary compositions comprising an essential oil such as cedar oil, tea oil, cardamom oil, lavender oil, cubeb oil, eucalyptus oil, mint oil, juniper oil, cypress oil, lemongrass oil, spruce oil, pine oil, fir oil, Douglas fir oil, wormwood oil, caraway oil, cumin oil, patchouli oil, sage oil, Inula oil, tansy oil, angelica oil calamus oil, ginger oil, thyme oil, Origanum oil, rosemary oil, nutmeg oil, coriander oil, geranium oil, carrot seed oil, yarrow herb or flower oil are disclosed. The essential oil may be present in the form of a complex with an organic acid or a mixture of organic acids including valerian, isovalerian, lactic, butyric, acetic, propionic, formic, benzoic, pelargonic, salicylic, malonic, citric, phthalic, tartaric, oxalic, malic, shikintic, fumaric, almond, cinnamic or derivatives thereof, and a metal including molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, or salts or oxides thereof. The compositions may be for the treatment and/or prevention of protozoan diseases in animals. Methods of manufacturing the veterinary compositions are also disclosed.

Veterinary compositions comprising an essential oil such as cedar oil, tea oil, cardamom oil, lavender oil, cubeb oil, eucalyptus oil, mint oil, juniper oil, cypress oil, lemongrass oil, spruce oil, pine oil, fir oil, Douglas fir oil, wormwood oil, caraway oil, cumin oil, patchouli oil, sage oil, Inula oil, tansy oil, angelica oil calamus oil, ginger oil, thyme oil, Origanum oil, rosemary oil, nutmeg oil, coriander oil, geranium oil, carrot seed oil, yarrow herb or flower oil are disclosed. The essential oil may be present in the form of a complex with an organic acid or a mixture of organic acids including valerian, isovalerian, lactic, butyric, acetic, propionic, formic, benzoic, pelargonic, salicylic, malonic, citric, phthalic, tartaric, oxalic, malic, shikintic, fumaric, almond, cinnamic or derivatives thereof, and a metal including molybdenum, cobalt, nickel, chromium, zinc, bismuth, copper, manganese, selenium, iron, or salts or oxides thereof. The compositions may be for the treatment and/or prevention of protozoan diseases in animals. Methods of manufacturing the veterinary compositions are also disclosed.

The present invention relates to a method of treating meningioma including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Coptis chinensis, Phellodendron amurense, Glycyrrhiza uralensis, Atractylodes lancea, Artemisia carvifolia, Anemarrhena asphodeloides, and Cortex Lycii.

The present invention relates to a method of treating meningioma including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Coptis chinensis, Phellodendron amurense, Glycyrrhiza uralensis, Atractylodes lancea, Artemisia carvifolia, Anemarrhena asphodeloides, and Cortex Lycii.

The present invention relates to a method of treating meningioma including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising Coptis chinensis, Phellodendron amurense, Glycyrrhiza uralensis, Atractylodes lancea, Artemisia carvifolia, Anemarrhena asphodeloides, and Cortex Lycii.